Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.

INTRODUCTION: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and expl...

Full description

Bibliographic Details
Main Authors: Hannock Tweya, Caryl Feldacker, Janne Estill, Andreas Jahn, Wingston Ng'ambi, Anne Ben-Smith, Olivia Keiser, Mphatso Bokosi, Matthias Egger, Colin Speight, Joe Gumulira, Sam Phiri
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3784425?pdf=render
_version_ 1819263852141871104
author Hannock Tweya
Caryl Feldacker
Janne Estill
Andreas Jahn
Wingston Ng'ambi
Anne Ben-Smith
Olivia Keiser
Mphatso Bokosi
Matthias Egger
Colin Speight
Joe Gumulira
Sam Phiri
author_facet Hannock Tweya
Caryl Feldacker
Janne Estill
Andreas Jahn
Wingston Ng'ambi
Anne Ben-Smith
Olivia Keiser
Mphatso Bokosi
Matthias Egger
Colin Speight
Joe Gumulira
Sam Phiri
author_sort Hannock Tweya
collection DOAJ
description INTRODUCTION: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and explain reasons for ART discontinuation using our active tracing program to further improve ART retention programs and policies. METHODS: We identified adult ART patients who missed clinic appointment by more than 3 weeks between January 2006 and December 2010, assuming that such patients would miss their doses of antiretroviral drugs. Patients considered LTFU who consented during ART registration were traced by phone or home visits; true ART status after tracing was documented. Reasons for ART discontinuation were also recorded for those who stopped ART. RESULTS: Of the 4,560 suspected LTFU cases, 1,384 (30%) could not be traced. Of the 3,176 successfully traced patients, 952 (30%) were dead and 2,224 (70%) were alive, of which 2,183 (99.5%) started ART according to phone-based self-reports or physical verification during in-person interviews. Of those who started ART, 957 (44%) stopped ART and 1,226 (56%) reported still taking ART at the time of interview by sourcing drugs from another clinic, using alternative ART sources or making brief ART interruptions. Among 940 cases with reasons for ART discontinuations, failure to remember (17%), too weak/sick (12%), travel (46%), and lack of transport to the clinic (16%) were frequently cited; reasons differed by gender. CONCLUSION: The LTFU category comprises sizeable proportions of patients still taking ART that may potentially bias retention estimates and misdirect resources at the clinic and national levels if not properly accounted for. Clinics should consider further decentralization efforts, increasing drug allocations for frequent travels, and improving communication on patient transfers between clinics to increase retention and adherence.
first_indexed 2024-12-23T20:20:10Z
format Article
id doaj.art-fa230b36efbc47e1993bc7dc4e810b8a
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T20:20:10Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-fa230b36efbc47e1993bc7dc4e810b8a2022-12-21T17:32:34ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0189e7576110.1371/journal.pone.0075761Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.Hannock TweyaCaryl FeldackerJanne EstillAndreas JahnWingston Ng'ambiAnne Ben-SmithOlivia KeiserMphatso BokosiMatthias EggerColin SpeightJoe GumuliraSam PhiriINTRODUCTION: Patients who are lost to follow-up (LTFU) while on antiretroviral therapy (ART) pose challenges to the long-term success of ART programs. We describe the extent to which patients considered LTFU are misclassified as true disengagement from care when they are still alive on ART and explain reasons for ART discontinuation using our active tracing program to further improve ART retention programs and policies. METHODS: We identified adult ART patients who missed clinic appointment by more than 3 weeks between January 2006 and December 2010, assuming that such patients would miss their doses of antiretroviral drugs. Patients considered LTFU who consented during ART registration were traced by phone or home visits; true ART status after tracing was documented. Reasons for ART discontinuation were also recorded for those who stopped ART. RESULTS: Of the 4,560 suspected LTFU cases, 1,384 (30%) could not be traced. Of the 3,176 successfully traced patients, 952 (30%) were dead and 2,224 (70%) were alive, of which 2,183 (99.5%) started ART according to phone-based self-reports or physical verification during in-person interviews. Of those who started ART, 957 (44%) stopped ART and 1,226 (56%) reported still taking ART at the time of interview by sourcing drugs from another clinic, using alternative ART sources or making brief ART interruptions. Among 940 cases with reasons for ART discontinuations, failure to remember (17%), too weak/sick (12%), travel (46%), and lack of transport to the clinic (16%) were frequently cited; reasons differed by gender. CONCLUSION: The LTFU category comprises sizeable proportions of patients still taking ART that may potentially bias retention estimates and misdirect resources at the clinic and national levels if not properly accounted for. Clinics should consider further decentralization efforts, increasing drug allocations for frequent travels, and improving communication on patient transfers between clinics to increase retention and adherence.http://europepmc.org/articles/PMC3784425?pdf=render
spellingShingle Hannock Tweya
Caryl Feldacker
Janne Estill
Andreas Jahn
Wingston Ng'ambi
Anne Ben-Smith
Olivia Keiser
Mphatso Bokosi
Matthias Egger
Colin Speight
Joe Gumulira
Sam Phiri
Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
PLoS ONE
title Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
title_full Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
title_fullStr Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
title_full_unstemmed Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
title_short Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
title_sort are they really lost true status and reasons for treatment discontinuation among hiv infected patients on antiretroviral therapy considered lost to follow up in urban malawi
url http://europepmc.org/articles/PMC3784425?pdf=render
work_keys_str_mv AT hannocktweya aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT carylfeldacker aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT janneestill aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT andreasjahn aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT wingstonngambi aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT annebensmith aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT oliviakeiser aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT mphatsobokosi aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT matthiasegger aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT colinspeight aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT joegumulira aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi
AT samphiri aretheyreallylosttruestatusandreasonsfortreatmentdiscontinuationamonghivinfectedpatientsonantiretroviraltherapyconsideredlosttofollowupinurbanmalawi